A Study to Find a Suitable Dose of Exl-111 for Further Research

Abroad (travel likely)RecruitingPHASE1

Conditions

Allergic Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CMAX, Adelaide, South Australia, Australia
Contact: Study coordinator (Dr. Sepehr Shakib) · cmax@cmax.com.au · +61870887900
Contact: Principal Investigator (Dr. Sepehr Shakib)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines

Allergic Diseases · Chronic Spontaneous Urticaria (CSU)

Abroad (travel likely)RecruitingPHASE2

Sofia, Bulgaria · Sofia, Bulgaria

Impact of Help-Seeking Behaviors on Allergic Rhinitis and Mental Health: A Longitudinal Study

Mental Health Conditions · Allergic

Abroad (travel likely)Recruiting

West Palm Beach, United States

Biobanking for Biomarkers In Respiratory Disease, Allergic Diseases and/or Mast Cell Disorders

Allergic Diseases · Asthma · Mast Cell Disorders

Abroad (travel likely)Recruiting

Toulouse, France

PollenVax Subcutaneous Immunotherapy for Mugwort Pollen-Induced Allergic Rhinitis

Rhinitis Allergic

Abroad (travel likely)RecruitingPHASE2

Almaty, Kazakhstan